nodes	percent_of_prediction	percent_of_DWPC	metapath
Entacapone—Dizziness—Ifosfamide—testicular cancer	0.000813	0.000813	CcSEcCtD
Entacapone—Pharyngitis—Methotrexate—testicular cancer	0.000812	0.000812	CcSEcCtD
Entacapone—Urinary tract disorder—Methotrexate—testicular cancer	0.000808	0.000808	CcSEcCtD
Entacapone—Hepatobiliary disease—Epirubicin—testicular cancer	0.000807	0.000807	CcSEcCtD
Entacapone—Weight increased—Doxorubicin—testicular cancer	0.000806	0.000806	CcSEcCtD
Entacapone—Epistaxis—Epirubicin—testicular cancer	0.000805	0.000805	CcSEcCtD
Entacapone—Urethral disorder—Methotrexate—testicular cancer	0.000802	0.000802	CcSEcCtD
Entacapone—Weight decreased—Doxorubicin—testicular cancer	0.000801	0.000801	CcSEcCtD
Entacapone—Sinusitis—Epirubicin—testicular cancer	0.0008	0.0008	CcSEcCtD
Entacapone—Feeling abnormal—Etoposide—testicular cancer	0.0008	0.0008	CcSEcCtD
Entacapone—Hyperglycaemia—Doxorubicin—testicular cancer	0.000799	0.000799	CcSEcCtD
Entacapone—Nausea—Dactinomycin—testicular cancer	0.000797	0.000797	CcSEcCtD
Entacapone—Agranulocytosis—Epirubicin—testicular cancer	0.000796	0.000796	CcSEcCtD
Entacapone—Pneumonia—Doxorubicin—testicular cancer	0.000794	0.000794	CcSEcCtD
Entacapone—Gastrointestinal pain—Etoposide—testicular cancer	0.000794	0.000794	CcSEcCtD
Entacapone—Visual impairment—Methotrexate—testicular cancer	0.000789	0.000789	CcSEcCtD
Entacapone—Vomiting—Ifosfamide—testicular cancer	0.000781	0.000781	CcSEcCtD
Entacapone—Hypersensitivity—Cisplatin—testicular cancer	0.000781	0.000781	CcSEcCtD
Entacapone—Bradycardia—Epirubicin—testicular cancer	0.00078	0.00078	CcSEcCtD
Entacapone—Rash—Ifosfamide—testicular cancer	0.000775	0.000775	CcSEcCtD
Entacapone—Dermatitis—Ifosfamide—testicular cancer	0.000774	0.000774	CcSEcCtD
Entacapone—Erythema multiforme—Methotrexate—testicular cancer	0.000774	0.000774	CcSEcCtD
Entacapone—Neuropathy peripheral—Doxorubicin—testicular cancer	0.000774	0.000774	CcSEcCtD
Entacapone—Urticaria—Etoposide—testicular cancer	0.000771	0.000771	CcSEcCtD
Entacapone—Haemoglobin—Epirubicin—testicular cancer	0.00077	0.00077	CcSEcCtD
Entacapone—Abdominal pain—Etoposide—testicular cancer	0.000767	0.000767	CcSEcCtD
Entacapone—Body temperature increased—Etoposide—testicular cancer	0.000767	0.000767	CcSEcCtD
Entacapone—Conjunctivitis—Doxorubicin—testicular cancer	0.000767	0.000767	CcSEcCtD
Entacapone—Urinary tract infection—Doxorubicin—testicular cancer	0.000767	0.000767	CcSEcCtD
Entacapone—Hepatitis—Epirubicin—testicular cancer	0.000766	0.000766	CcSEcCtD
Entacapone—Haemorrhage—Epirubicin—testicular cancer	0.000766	0.000766	CcSEcCtD
Entacapone—Eye disorder—Methotrexate—testicular cancer	0.000765	0.000765	CcSEcCtD
Entacapone—Hypoaesthesia—Epirubicin—testicular cancer	0.000762	0.000762	CcSEcCtD
Entacapone—Asthenia—Cisplatin—testicular cancer	0.00076	0.00076	CcSEcCtD
Entacapone—Pharyngitis—Epirubicin—testicular cancer	0.00076	0.00076	CcSEcCtD
Entacapone—Cardiac disorder—Methotrexate—testicular cancer	0.00076	0.00076	CcSEcCtD
Entacapone—Sweating—Doxorubicin—testicular cancer	0.000757	0.000757	CcSEcCtD
Entacapone—Urinary tract disorder—Epirubicin—testicular cancer	0.000756	0.000756	CcSEcCtD
Entacapone—Haematuria—Doxorubicin—testicular cancer	0.000753	0.000753	CcSEcCtD
Entacapone—Urethral disorder—Epirubicin—testicular cancer	0.000751	0.000751	CcSEcCtD
Entacapone—Hepatobiliary disease—Doxorubicin—testicular cancer	0.000747	0.000747	CcSEcCtD
Entacapone—Epistaxis—Doxorubicin—testicular cancer	0.000745	0.000745	CcSEcCtD
Entacapone—Sinusitis—Doxorubicin—testicular cancer	0.000741	0.000741	CcSEcCtD
Entacapone—Visual impairment—Epirubicin—testicular cancer	0.000738	0.000738	CcSEcCtD
Entacapone—Agranulocytosis—Doxorubicin—testicular cancer	0.000737	0.000737	CcSEcCtD
Entacapone—Nausea—Ifosfamide—testicular cancer	0.00073	0.00073	CcSEcCtD
Entacapone—Diarrhoea—Cisplatin—testicular cancer	0.000725	0.000725	CcSEcCtD
Entacapone—Erythema multiforme—Epirubicin—testicular cancer	0.000724	0.000724	CcSEcCtD
Entacapone—Alopecia—Methotrexate—testicular cancer	0.000723	0.000723	CcSEcCtD
Entacapone—Bradycardia—Doxorubicin—testicular cancer	0.000721	0.000721	CcSEcCtD
Entacapone—Mental disorder—Methotrexate—testicular cancer	0.000717	0.000717	CcSEcCtD
Entacapone—Eye disorder—Epirubicin—testicular cancer	0.000716	0.000716	CcSEcCtD
Entacapone—Hypersensitivity—Etoposide—testicular cancer	0.000715	0.000715	CcSEcCtD
Entacapone—Malnutrition—Methotrexate—testicular cancer	0.000712	0.000712	CcSEcCtD
Entacapone—Haemoglobin—Doxorubicin—testicular cancer	0.000712	0.000712	CcSEcCtD
Entacapone—Flushing—Epirubicin—testicular cancer	0.000711	0.000711	CcSEcCtD
Entacapone—Cardiac disorder—Epirubicin—testicular cancer	0.000711	0.000711	CcSEcCtD
Entacapone—Hepatitis—Doxorubicin—testicular cancer	0.000709	0.000709	CcSEcCtD
Entacapone—Haemorrhage—Doxorubicin—testicular cancer	0.000709	0.000709	CcSEcCtD
Entacapone—Hypoaesthesia—Doxorubicin—testicular cancer	0.000705	0.000705	CcSEcCtD
Entacapone—Pharyngitis—Doxorubicin—testicular cancer	0.000703	0.000703	CcSEcCtD
Entacapone—Urinary tract disorder—Doxorubicin—testicular cancer	0.0007	0.0007	CcSEcCtD
Entacapone—Dysgeusia—Methotrexate—testicular cancer	0.000698	0.000698	CcSEcCtD
Entacapone—Asthenia—Etoposide—testicular cancer	0.000696	0.000696	CcSEcCtD
Entacapone—Urethral disorder—Doxorubicin—testicular cancer	0.000695	0.000695	CcSEcCtD
Entacapone—Back pain—Methotrexate—testicular cancer	0.000689	0.000689	CcSEcCtD
Entacapone—Pruritus—Etoposide—testicular cancer	0.000687	0.000687	CcSEcCtD
Entacapone—Visual impairment—Doxorubicin—testicular cancer	0.000683	0.000683	CcSEcCtD
Entacapone—Alopecia—Epirubicin—testicular cancer	0.000677	0.000677	CcSEcCtD
Entacapone—Vomiting—Cisplatin—testicular cancer	0.000674	0.000674	CcSEcCtD
Entacapone—Vision blurred—Methotrexate—testicular cancer	0.000671	0.000671	CcSEcCtD
Entacapone—Mental disorder—Epirubicin—testicular cancer	0.000671	0.000671	CcSEcCtD
Entacapone—Erythema multiforme—Doxorubicin—testicular cancer	0.00067	0.00067	CcSEcCtD
Entacapone—Rash—Cisplatin—testicular cancer	0.000668	0.000668	CcSEcCtD
Entacapone—Dermatitis—Cisplatin—testicular cancer	0.000667	0.000667	CcSEcCtD
Entacapone—Malnutrition—Epirubicin—testicular cancer	0.000667	0.000667	CcSEcCtD
Entacapone—Diarrhoea—Etoposide—testicular cancer	0.000664	0.000664	CcSEcCtD
Entacapone—Eye disorder—Doxorubicin—testicular cancer	0.000662	0.000662	CcSEcCtD
Entacapone—Ill-defined disorder—Methotrexate—testicular cancer	0.000661	0.000661	CcSEcCtD
Entacapone—Flushing—Doxorubicin—testicular cancer	0.000658	0.000658	CcSEcCtD
Entacapone—Cardiac disorder—Doxorubicin—testicular cancer	0.000658	0.000658	CcSEcCtD
Entacapone—Flatulence—Epirubicin—testicular cancer	0.000657	0.000657	CcSEcCtD
Entacapone—Tension—Epirubicin—testicular cancer	0.000654	0.000654	CcSEcCtD
Entacapone—Dysgeusia—Epirubicin—testicular cancer	0.000653	0.000653	CcSEcCtD
Entacapone—Nervousness—Epirubicin—testicular cancer	0.000648	0.000648	CcSEcCtD
Entacapone—Back pain—Epirubicin—testicular cancer	0.000645	0.000645	CcSEcCtD
Entacapone—Malaise—Methotrexate—testicular cancer	0.000642	0.000642	CcSEcCtD
Entacapone—Dizziness—Etoposide—testicular cancer	0.000642	0.000642	CcSEcCtD
Entacapone—Muscle spasms—Epirubicin—testicular cancer	0.000641	0.000641	CcSEcCtD
Entacapone—Vertigo—Methotrexate—testicular cancer	0.00064	0.00064	CcSEcCtD
Entacapone—Leukopenia—Methotrexate—testicular cancer	0.000638	0.000638	CcSEcCtD
Entacapone—Nausea—Cisplatin—testicular cancer	0.000629	0.000629	CcSEcCtD
Entacapone—Vision blurred—Epirubicin—testicular cancer	0.000628	0.000628	CcSEcCtD
Entacapone—Alopecia—Doxorubicin—testicular cancer	0.000626	0.000626	CcSEcCtD
Entacapone—Cough—Methotrexate—testicular cancer	0.000622	0.000622	CcSEcCtD
Entacapone—Mental disorder—Doxorubicin—testicular cancer	0.000621	0.000621	CcSEcCtD
Entacapone—Ill-defined disorder—Epirubicin—testicular cancer	0.000619	0.000619	CcSEcCtD
Entacapone—Convulsion—Methotrexate—testicular cancer	0.000617	0.000617	CcSEcCtD
Entacapone—Vomiting—Etoposide—testicular cancer	0.000617	0.000617	CcSEcCtD
Entacapone—Malnutrition—Doxorubicin—testicular cancer	0.000617	0.000617	CcSEcCtD
Entacapone—Agitation—Epirubicin—testicular cancer	0.000613	0.000613	CcSEcCtD
Entacapone—Rash—Etoposide—testicular cancer	0.000612	0.000612	CcSEcCtD
Entacapone—Dermatitis—Etoposide—testicular cancer	0.000611	0.000611	CcSEcCtD
Entacapone—Headache—Etoposide—testicular cancer	0.000608	0.000608	CcSEcCtD
Entacapone—Flatulence—Doxorubicin—testicular cancer	0.000608	0.000608	CcSEcCtD
Entacapone—Chest pain—Methotrexate—testicular cancer	0.000607	0.000607	CcSEcCtD
Entacapone—Myalgia—Methotrexate—testicular cancer	0.000607	0.000607	CcSEcCtD
Entacapone—Tension—Doxorubicin—testicular cancer	0.000605	0.000605	CcSEcCtD
Entacapone—Dysgeusia—Doxorubicin—testicular cancer	0.000604	0.000604	CcSEcCtD
Entacapone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.000602	0.000602	CcSEcCtD
Entacapone—Malaise—Epirubicin—testicular cancer	0.000601	0.000601	CcSEcCtD
Entacapone—Discomfort—Methotrexate—testicular cancer	0.000599	0.000599	CcSEcCtD
Entacapone—Nervousness—Doxorubicin—testicular cancer	0.000599	0.000599	CcSEcCtD
Entacapone—Vertigo—Epirubicin—testicular cancer	0.000599	0.000599	CcSEcCtD
Entacapone—Syncope—Epirubicin—testicular cancer	0.000598	0.000598	CcSEcCtD
Entacapone—Leukopenia—Epirubicin—testicular cancer	0.000597	0.000597	CcSEcCtD
Entacapone—Back pain—Doxorubicin—testicular cancer	0.000597	0.000597	CcSEcCtD
Entacapone—Muscle spasms—Doxorubicin—testicular cancer	0.000593	0.000593	CcSEcCtD
Entacapone—Palpitations—Epirubicin—testicular cancer	0.000589	0.000589	CcSEcCtD
Entacapone—Confusional state—Methotrexate—testicular cancer	0.000586	0.000586	CcSEcCtD
Entacapone—Loss of consciousness—Epirubicin—testicular cancer	0.000586	0.000586	CcSEcCtD
Entacapone—Cough—Epirubicin—testicular cancer	0.000582	0.000582	CcSEcCtD
Entacapone—Vision blurred—Doxorubicin—testicular cancer	0.000581	0.000581	CcSEcCtD
Entacapone—Convulsion—Epirubicin—testicular cancer	0.000578	0.000578	CcSEcCtD
Entacapone—Nausea—Etoposide—testicular cancer	0.000577	0.000577	CcSEcCtD
Entacapone—Hypertension—Epirubicin—testicular cancer	0.000576	0.000576	CcSEcCtD
Entacapone—Ill-defined disorder—Doxorubicin—testicular cancer	0.000572	0.000572	CcSEcCtD
Entacapone—Nervous system disorder—Methotrexate—testicular cancer	0.00057	0.00057	CcSEcCtD
Entacapone—Thrombocytopenia—Methotrexate—testicular cancer	0.000569	0.000569	CcSEcCtD
Entacapone—Myalgia—Epirubicin—testicular cancer	0.000568	0.000568	CcSEcCtD
Entacapone—Chest pain—Epirubicin—testicular cancer	0.000568	0.000568	CcSEcCtD
Entacapone—Agitation—Doxorubicin—testicular cancer	0.000567	0.000567	CcSEcCtD
Entacapone—Anxiety—Epirubicin—testicular cancer	0.000566	0.000566	CcSEcCtD
Entacapone—Skin disorder—Methotrexate—testicular cancer	0.000565	0.000565	CcSEcCtD
Entacapone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.000564	0.000564	CcSEcCtD
Entacapone—Hyperhidrosis—Methotrexate—testicular cancer	0.000562	0.000562	CcSEcCtD
Entacapone—Discomfort—Epirubicin—testicular cancer	0.000561	0.000561	CcSEcCtD
Entacapone—Malaise—Doxorubicin—testicular cancer	0.000556	0.000556	CcSEcCtD
Entacapone—Dry mouth—Epirubicin—testicular cancer	0.000555	0.000555	CcSEcCtD
Entacapone—Vertigo—Doxorubicin—testicular cancer	0.000554	0.000554	CcSEcCtD
Entacapone—Anorexia—Methotrexate—testicular cancer	0.000554	0.000554	CcSEcCtD
Entacapone—Syncope—Doxorubicin—testicular cancer	0.000553	0.000553	CcSEcCtD
Entacapone—Leukopenia—Doxorubicin—testicular cancer	0.000552	0.000552	CcSEcCtD
Entacapone—Confusional state—Epirubicin—testicular cancer	0.000549	0.000549	CcSEcCtD
Entacapone—Palpitations—Doxorubicin—testicular cancer	0.000545	0.000545	CcSEcCtD
Entacapone—Oedema—Epirubicin—testicular cancer	0.000544	0.000544	CcSEcCtD
Entacapone—Hypotension—Methotrexate—testicular cancer	0.000543	0.000543	CcSEcCtD
Entacapone—Loss of consciousness—Doxorubicin—testicular cancer	0.000542	0.000542	CcSEcCtD
Entacapone—Cough—Doxorubicin—testicular cancer	0.000538	0.000538	CcSEcCtD
Entacapone—Shock—Epirubicin—testicular cancer	0.000535	0.000535	CcSEcCtD
Entacapone—Convulsion—Doxorubicin—testicular cancer	0.000534	0.000534	CcSEcCtD
Entacapone—Nervous system disorder—Epirubicin—testicular cancer	0.000534	0.000534	CcSEcCtD
Entacapone—Thrombocytopenia—Epirubicin—testicular cancer	0.000533	0.000533	CcSEcCtD
Entacapone—Hypertension—Doxorubicin—testicular cancer	0.000533	0.000533	CcSEcCtD
Entacapone—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.00053	0.00053	CcSEcCtD
Entacapone—Skin disorder—Epirubicin—testicular cancer	0.000529	0.000529	CcSEcCtD
Entacapone—Hyperhidrosis—Epirubicin—testicular cancer	0.000526	0.000526	CcSEcCtD
Entacapone—Insomnia—Methotrexate—testicular cancer	0.000526	0.000526	CcSEcCtD
Entacapone—Chest pain—Doxorubicin—testicular cancer	0.000525	0.000525	CcSEcCtD
Entacapone—Myalgia—Doxorubicin—testicular cancer	0.000525	0.000525	CcSEcCtD
Entacapone—Anxiety—Doxorubicin—testicular cancer	0.000523	0.000523	CcSEcCtD
Entacapone—Paraesthesia—Methotrexate—testicular cancer	0.000522	0.000522	CcSEcCtD
Entacapone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.000522	0.000522	CcSEcCtD
Entacapone—Discomfort—Doxorubicin—testicular cancer	0.000519	0.000519	CcSEcCtD
Entacapone—Anorexia—Epirubicin—testicular cancer	0.000519	0.000519	CcSEcCtD
Entacapone—Dyspnoea—Methotrexate—testicular cancer	0.000518	0.000518	CcSEcCtD
Entacapone—Somnolence—Methotrexate—testicular cancer	0.000517	0.000517	CcSEcCtD
Entacapone—Dry mouth—Doxorubicin—testicular cancer	0.000514	0.000514	CcSEcCtD
Entacapone—Dyspepsia—Methotrexate—testicular cancer	0.000512	0.000512	CcSEcCtD
Entacapone—Hypotension—Epirubicin—testicular cancer	0.000508	0.000508	CcSEcCtD
Entacapone—Confusional state—Doxorubicin—testicular cancer	0.000508	0.000508	CcSEcCtD
Entacapone—Decreased appetite—Methotrexate—testicular cancer	0.000505	0.000505	CcSEcCtD
Entacapone—Oedema—Doxorubicin—testicular cancer	0.000503	0.000503	CcSEcCtD
Entacapone—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000502	0.000502	CcSEcCtD
Entacapone—Fatigue—Methotrexate—testicular cancer	0.000501	0.000501	CcSEcCtD
Entacapone—Pain—Methotrexate—testicular cancer	0.000497	0.000497	CcSEcCtD
Entacapone—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000496	0.000496	CcSEcCtD
Entacapone—Shock—Doxorubicin—testicular cancer	0.000495	0.000495	CcSEcCtD
Entacapone—Nervous system disorder—Doxorubicin—testicular cancer	0.000494	0.000494	CcSEcCtD
Entacapone—Thrombocytopenia—Doxorubicin—testicular cancer	0.000493	0.000493	CcSEcCtD
Entacapone—Insomnia—Epirubicin—testicular cancer	0.000492	0.000492	CcSEcCtD
Entacapone—Skin disorder—Doxorubicin—testicular cancer	0.000489	0.000489	CcSEcCtD
Entacapone—Paraesthesia—Epirubicin—testicular cancer	0.000489	0.000489	CcSEcCtD
Entacapone—Hyperhidrosis—Doxorubicin—testicular cancer	0.000487	0.000487	CcSEcCtD
Entacapone—Dyspnoea—Epirubicin—testicular cancer	0.000485	0.000485	CcSEcCtD
Entacapone—Somnolence—Epirubicin—testicular cancer	0.000484	0.000484	CcSEcCtD
Entacapone—Anorexia—Doxorubicin—testicular cancer	0.00048	0.00048	CcSEcCtD
Entacapone—Feeling abnormal—Methotrexate—testicular cancer	0.000479	0.000479	CcSEcCtD
Entacapone—Dyspepsia—Epirubicin—testicular cancer	0.000479	0.000479	CcSEcCtD
Entacapone—Gastrointestinal pain—Methotrexate—testicular cancer	0.000475	0.000475	CcSEcCtD
Entacapone—Decreased appetite—Epirubicin—testicular cancer	0.000473	0.000473	CcSEcCtD
Entacapone—Hypotension—Doxorubicin—testicular cancer	0.00047	0.00047	CcSEcCtD
Entacapone—Gastrointestinal disorder—Epirubicin—testicular cancer	0.00047	0.00047	CcSEcCtD
Entacapone—Fatigue—Epirubicin—testicular cancer	0.000469	0.000469	CcSEcCtD
Entacapone—Pain—Epirubicin—testicular cancer	0.000465	0.000465	CcSEcCtD
Entacapone—Constipation—Epirubicin—testicular cancer	0.000465	0.000465	CcSEcCtD
Entacapone—Urticaria—Methotrexate—testicular cancer	0.000462	0.000462	CcSEcCtD
Entacapone—Abdominal pain—Methotrexate—testicular cancer	0.00046	0.00046	CcSEcCtD
Entacapone—Body temperature increased—Methotrexate—testicular cancer	0.00046	0.00046	CcSEcCtD
Entacapone—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000459	0.000459	CcSEcCtD
Entacapone—Insomnia—Doxorubicin—testicular cancer	0.000455	0.000455	CcSEcCtD
Entacapone—Paraesthesia—Doxorubicin—testicular cancer	0.000452	0.000452	CcSEcCtD
Entacapone—Dyspnoea—Doxorubicin—testicular cancer	0.000449	0.000449	CcSEcCtD
Entacapone—Feeling abnormal—Epirubicin—testicular cancer	0.000448	0.000448	CcSEcCtD
Entacapone—Somnolence—Doxorubicin—testicular cancer	0.000448	0.000448	CcSEcCtD
Entacapone—Gastrointestinal pain—Epirubicin—testicular cancer	0.000445	0.000445	CcSEcCtD
Entacapone—Dyspepsia—Doxorubicin—testicular cancer	0.000443	0.000443	CcSEcCtD
Entacapone—Decreased appetite—Doxorubicin—testicular cancer	0.000438	0.000438	CcSEcCtD
Entacapone—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000435	0.000435	CcSEcCtD
Entacapone—Fatigue—Doxorubicin—testicular cancer	0.000434	0.000434	CcSEcCtD
Entacapone—Urticaria—Epirubicin—testicular cancer	0.000432	0.000432	CcSEcCtD
Entacapone—Pain—Doxorubicin—testicular cancer	0.000431	0.000431	CcSEcCtD
Entacapone—Constipation—Doxorubicin—testicular cancer	0.000431	0.000431	CcSEcCtD
Entacapone—Abdominal pain—Epirubicin—testicular cancer	0.00043	0.00043	CcSEcCtD
Entacapone—Body temperature increased—Epirubicin—testicular cancer	0.00043	0.00043	CcSEcCtD
Entacapone—Hypersensitivity—Methotrexate—testicular cancer	0.000428	0.000428	CcSEcCtD
Entacapone—Asthenia—Methotrexate—testicular cancer	0.000417	0.000417	CcSEcCtD
Entacapone—Feeling abnormal—Doxorubicin—testicular cancer	0.000415	0.000415	CcSEcCtD
Entacapone—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000412	0.000412	CcSEcCtD
Entacapone—Pruritus—Methotrexate—testicular cancer	0.000411	0.000411	CcSEcCtD
Entacapone—Hypersensitivity—Epirubicin—testicular cancer	0.000401	0.000401	CcSEcCtD
Entacapone—Urticaria—Doxorubicin—testicular cancer	0.0004	0.0004	CcSEcCtD
Entacapone—Abdominal pain—Doxorubicin—testicular cancer	0.000398	0.000398	CcSEcCtD
Entacapone—Body temperature increased—Doxorubicin—testicular cancer	0.000398	0.000398	CcSEcCtD
Entacapone—Diarrhoea—Methotrexate—testicular cancer	0.000398	0.000398	CcSEcCtD
Entacapone—Asthenia—Epirubicin—testicular cancer	0.00039	0.00039	CcSEcCtD
Entacapone—Pruritus—Epirubicin—testicular cancer	0.000385	0.000385	CcSEcCtD
Entacapone—Dizziness—Methotrexate—testicular cancer	0.000384	0.000384	CcSEcCtD
Entacapone—Diarrhoea—Epirubicin—testicular cancer	0.000372	0.000372	CcSEcCtD
Entacapone—Hypersensitivity—Doxorubicin—testicular cancer	0.000371	0.000371	CcSEcCtD
Entacapone—Vomiting—Methotrexate—testicular cancer	0.00037	0.00037	CcSEcCtD
Entacapone—Rash—Methotrexate—testicular cancer	0.000367	0.000367	CcSEcCtD
Entacapone—Dermatitis—Methotrexate—testicular cancer	0.000366	0.000366	CcSEcCtD
Entacapone—Headache—Methotrexate—testicular cancer	0.000364	0.000364	CcSEcCtD
Entacapone—Asthenia—Doxorubicin—testicular cancer	0.000361	0.000361	CcSEcCtD
Entacapone—Dizziness—Epirubicin—testicular cancer	0.00036	0.00036	CcSEcCtD
Entacapone—Pruritus—Doxorubicin—testicular cancer	0.000356	0.000356	CcSEcCtD
Entacapone—Vomiting—Epirubicin—testicular cancer	0.000346	0.000346	CcSEcCtD
Entacapone—Nausea—Methotrexate—testicular cancer	0.000345	0.000345	CcSEcCtD
Entacapone—Diarrhoea—Doxorubicin—testicular cancer	0.000344	0.000344	CcSEcCtD
Entacapone—Rash—Epirubicin—testicular cancer	0.000343	0.000343	CcSEcCtD
Entacapone—Dermatitis—Epirubicin—testicular cancer	0.000343	0.000343	CcSEcCtD
Entacapone—Headache—Epirubicin—testicular cancer	0.000341	0.000341	CcSEcCtD
Entacapone—Dizziness—Doxorubicin—testicular cancer	0.000333	0.000333	CcSEcCtD
Entacapone—Nausea—Epirubicin—testicular cancer	0.000323	0.000323	CcSEcCtD
Entacapone—Vomiting—Doxorubicin—testicular cancer	0.00032	0.00032	CcSEcCtD
Entacapone—Rash—Doxorubicin—testicular cancer	0.000317	0.000317	CcSEcCtD
Entacapone—Dermatitis—Doxorubicin—testicular cancer	0.000317	0.000317	CcSEcCtD
Entacapone—Headache—Doxorubicin—testicular cancer	0.000315	0.000315	CcSEcCtD
Entacapone—Nausea—Doxorubicin—testicular cancer	0.000299	0.000299	CcSEcCtD
